Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin lambda variable (I)-38 pseudogene (IGLVI-38, also called IGLV(I)-38 or V1-12P) is located within the immunoglobulin lambda locus on chromosome 22. It is annotated as an immunoglobulin variable (IG V) pseudogene and is non-functional, meaning it does not encode a functional antibody variable domain. Pseudogenes like IGLVI-38 arise due to mutations or deletions during evolution, rendering them incapable of producing functional proteins. Therefore, IGLVI-38 is not considered a therapeutic target or active molecular entity in human biology. The target name is accurately matched to a pseudogene, not a functional receptor or protein. It is not considered a therapeutic target and is not involved in known biological or disease pathways. There is nothing to suggest misspelling, but IGLVI-38 is not a protein-coding gene or targetable molecule. IGLVI-38 is a pseudogene and not a functional molecular target for therapeutics, receptors, enzymes, or other drug classes. Any attempt to classify it as a therapeutic target, biomarker, or participant in drug mechanisms is scientifically incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin lambda variable (I)-38 pseudogene (IGLVI-38).